References
- 1. A. R. Shalita, W. J. Cunningham, J. J. Leyden, P. E. Pochi and J. S. Strauss, Isotretinoin treatment of acne and disorders: An update, J. Am. Acad. Dermatol. 9 (1983) 629-638. DOI: 10.1016/S0190-9622(83)70176-3.
- 2. F. L. Meyskens, G. E. Goodman and D. S. Alberts, 13-Cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer, Crit. Rev. Oncol. Hematol. 3 (1985) 75-101; DOI: 10.1016/S1040-8428(85)80040-8.
- 3. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu and X. Yang, Isotretinoin-loaded solid lipid nanoparticles nanoparticles with skin targeting for topical delivery, Int. J. Pharm. 328 (2007) 191-195; DOI: 10.1016/j.ijpharm.2006.08.007.
- 4. S. Yang, J. Zhu, Y. Lu, B. Liang and C. Yang, Body distribution of camptothecin solid lipid nanoparticles after oral administration, Pharm. Res. 16 (1999) 751-757.
- 5. V. Jenning, A. Gysler, M. Schafer-Korting and S. H. Gohla. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin, Eur. J. Pharm. Biopharm. 49 (2000) 211-218.
- 6. R. H. Müller, M. Radtke and S. A Wissing, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations, Adv. Drug Deliv. Rev. 54 (2002) S131-S155; DOI: 10.1016/S0169-409X(02)00118-7.
- 7. P. Ahlin, J. Kristl, S. Pecar, J. [trancar and M. [entjurc, The effect of lipophilicity of spin-labeled compounds on their distribution in solid lipid nanoparticles dispersions studied by electron paramagnetic resonance, J. Pharm. Sci. 92 (2003) 58-66; DOI: 10.1002/jps.10277.
- 8. V. P. Torchilin, Nanoparticle as Drug Carriers, Imperial College Press, London, 2006, pp. 187-205.
- 9. R. H. Müller, K. Mäder and S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art, Eur. J. Pharm. Biopharm. 50 (2000) 161-177; DOI: 10.1016/S0939-6411(00)00087-4.
- 10. S. A. Wissing and R. H. Müller, The influence of solid lipid nanoparticles on skin hydration and viscoelasticity-in vivo study, Eur. J. Pharm. Biopharm. 56 (2003) 67-72; DOI: 10.1016/S0939-6411(03)00040-7.
- 11. S. A. Wissing and R. H. Müller, Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration, J. Control. Release 81 (2002) 225-233.
- 12. R. Sivaramakrishnan, C. Nakamura, W. Mehnert, H. C. Korting, K. D. Kramer and M. Schafer-Korting. Glucocorticoid entrapment into lipid carriers - characterisation by parelectric spectroscopy and influence on dermal uptake, J. Control. Release 97 (2004) 493-502; DOI: 10.1016/j.jconrel.2004.04.001.
- 13. E. B. Souto and R. H. Müller, The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents, Pharmazie 61 (2006) 431-437.
- 14. P. Ahlin, J. Kristl and J. Šmid-Kobar, Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions, Acta Pharm. 48 (1998) 257-267.
- 15. V. Jenning and S. H. Gohla, Encapsulation of retinoids in solid lipid nanoparticles (SLN). J. Microencapsul.18 (2001) 149-158.
- 16. S. D. Mandawgade and V. B. Patravale. Development of SLNs from natural lipids: application to topical delivery of tretinoin, Int. J. Pharm. 363 (2008) 132-138; DOI: 10.1016/j.ijpharm.2008.06.028.
- 17. M. Joshi and V. Patravale, Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of valdecoxib, Drug Dev. Ind. Pharm. 32 (2006) 911-918.
- 18. United States Pharmacopoeia 30, National Formulary 25, The United States Pharmacopoeial Convention, 2007, p.p. 2479, 2008.
- 19. K. A. Shah, A. A. Date, M. D. Joshi and V. B. Patravale, Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery, Int. J. Pharm. 345 (2007) 163-171; DOI: 10.1016/j.ijpharm.2007.05.061.
- 20. G. Ioele, E. Cione, A. Risoli, G. Genchi and G. Ragno, Accelerated photostability study of tretinoin and isotretinoin in liposome formulations, Int. J. Pharm. 293 (2005) 251-260. DOI: 10.1016/j.ijpharm.2005.01.012.
- 21. S. Wissing and R. Müller, The influence of the crystallinity of lipid nanoparticles on their occlusive properties, Int. J. Pharm. 242 (2002) 377-379.
- 22. E. B. Souto, S. A. Wissing, C. M. Barbosa and R. H. Müller, Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery, Int. J. Pharm. 278 (2004) 71-77; DOI: 10.1016/j.ijpharm.2004.02.032.
- 23. J. Draize, G.Woodard and H. Calvery, Methods for the study of irritation and toxicity of substances topically applied to skin and mucous membranes, J. Pharmacol Exp. Ther. 82 (1944) 377- 390.
- 24. K. F. Brain, K. A. Walters and A. C. Watkinson, Dermatological and Transdermal Formulation, Marcel Dekker Inc., New York 2002.
- 25. M. R. Jaafari, N. Bavarsad, B. S. Bazzaz, A. Samiei, D. Soroush and S. Ghorbani, Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB/c mice, Antimicrob. Agents Chemother. 53 (2009) 2259-2265.
- 26. H. Chen, X. Chang, D. Du, W. Liu, J. Liu, T. Weng, Y. Yang, H. XU and X. Yang, Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting, J. Control. Release 110 (2006) 296-306; DOI: 10.1016/j.jconrel.2005.09.052.
- 27. P. Treffel and B. Gabard. Skin penetration and sun protection factor of ultra-violet filters from two vehicles, Pharm. Res. 13 (1996) 770-774; DOI: 10.1023/A:1016012019483.
- 28. C. Couteau, N. Perez Cullel, A. E. Connan and L. J. Coiffard, Stripping method to quantify absorption of two sunscreens in human, Int. J. Pharm. 222 (2001) 153-157.
- 29. V. Sarveiya, S. Risk and H. A. Benson, Liquid chromatographic assay for common sunscreen agents: application to in vivo assessment of skin penetration and systemic absorption in human volunteers, J. Chromatogr B Analyt. Technol. Biomed. Life Sci. 803 (2004) 225-231; DOI: 10.1016/j.jchromb.2003.12.022.
- 30. S. Golmohammadzadeh, M. R. Jaafari and N. Khalili, Evaluation of liposomal and conventional formulations of octyl methoxycinnamate on human percutaneous absorption using the stripping method, J. Cosmet Sci. 59 (2008) 385-398; DOI: 10.1111/j.1468-2494.2009.00517_1.x.
- 31. D. Hou, C. Xie, K. Huang and C. Zhu, The production and characteristics of solid lipid nanoparticles (SLNs), Biomaterials 24 (2003) 1781-1785; DOI: 10.1016/S0142-9612(02)00578-1.
- 32. L. H. Reddy, K. Vivek, N. Bakshi and R. S. Murthy, Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation, Pharm. Dev. Technol. 11 (2006) 167-177.
- 33. A. Saupe, S. A. Wissing, A. Lenk, C. Schmidt, R. H. Müller, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) - structural investigations on two different carrier systems, Biomed. Mater. Eng. 15 (2005) 393-402.
- 34. Z. Li, L. Yu, L. Zheng and F. Geng, Studies on crystallinity state of puerarin loaded solid lipid nanoparticles prepared by double emulsion method, J. Therm. Anal. Calorim. 99 (2010) 689-693. DOI: 10.1007/s10973-009-0127-z.
- 35. W. Mehnert and K. Mader, Solid lipid nanoparticles: production, characterization and applications, Adv. Drug Deliv. Rev. 47 (2001) 165-196.
- 36. Y. Yamaguchi, T. Nagasawa, N. M. Nakamura Takenaga, M. Mizoguchi, S. Kawai, Y. Mizushima and R. Igarashi, Successful treatment of photo-damaged skin of nano-scale atRA particles using a novel transdermal delivery, J. Control. Release 104 (2005) 29-40; DOI: 10.1016/j.jconrel.2004.11.036.
- 37. Z. Mei, H. Chen, T. Weng, Y. Yang and X. Yang, Solid lipid nanoparticle and microemulsion for topical delivery of triptolide, Eur. J. Pharm. Biopharm. 56 (2003) 189-196; DOI: 10.1016/S0939-6411(03)00067-5.
- 38. C. Santos Maia, W. Mehnert, M. Schaller, H. C. Korting, A. Gysler, A. Haberland and M. Schäfer-Korting, Drug targeting by solid lipid nanoparticles for dermal use, J. Drug Target. 10 (2002) 489-495.
- 39. J. Stecova, W. Mehnert, T. Blaschke, B. Kleuser, R. Sivaramakrishnan, C. C. Zouboulis, H. Seltmann, H. C. Korting, K. D. Kramer and M. Schäfer-Korting, Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake, Pharm. Res. 24 (2007) 991-1000; DOI: 10.1007/s11095-006-9225-9.
- 40. D. D. Verma, S. Verma S, G. Blume and A. Fahr A, Particle size of liposomes influences dermal delivery of substances into skin, Int. J. Pharm. 258 (2003) 141-151; DOI: 10.1016/S0378-5173(03)00183-2.
- 41. M. Sentjurc, K. Vrhovnik and J. Kristl, Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method, J. Control. Release 59 (1999) 87-97; DOI: 10.1016/S0168-3659(98)00181-3.